Search Results for keywords:"National Institutes of Health"

The National Institute of Allergy and Infectious Diseases has announced a closed meeting to be held on January 28, 2025. This meeting will take place from 10:00 a.m. to 12:00 p.m. and will focus on reviewing and evaluating grant applications. The discussions will be private to prevent the disclosure of confidential information, such as trade secrets or personal data related to the grant applications. The meeting will be conducted via video at the National Institutes of Health in Rockville, Maryland.

The National Human Genome Research Institute is holding the 92nd meeting of the National Advisory Council for Human Genome Research. This meeting will include both open and closed sessions on February 22-23, 2021. The open session, which will be live-streamed for public viewing, will feature reports from the Institute Director and Program Staff. The closed sessions will focus on discussing confidential grant applications and will not be open to the public.

The National Institutes of Health (NIH) is offering a government-owned invention for licensing. This invention is a vaccine that uses a virus vector called VSV-EBOV to express the spike protein of the SARS-CoV-2 virus, which causes COVID-19. The vaccine has shown effective protection against the virus in animal tests, and it only requires a single dose. It is designed to be inexpensive to produce and provides high levels of antibodies to fight COVID-19.

The National Institutes of Health (NIH) is holding several closed virtual meetings organized by the Center for Scientific Review in April 2025. These meetings are not open to the public because they involve discussing grant applications, which contain sensitive information such as trade secrets and personal data. Various scientific review panels will meet to evaluate grant proposals in areas like epidemiology, oncology, and data management. These evaluations help allocate funding for important health research projects.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development is holding a closed meeting on April 21, 2025. This meeting will discuss contract proposals and is not open to the public due to confidentiality and privacy concerns. The meeting will be held virtually from 1:00 p.m. to 5:00 p.m. For more information or questions, Vera A. Cherkasova, Ph.D., from the Scientific Review Branch, can be contacted at vera.cherkasova@nih.gov.

The National Institutes of Health (NIH) has announced two upcoming closed meetings of the National Institute on Drug Abuse Special Emphasis Panel. These meetings will take place on April 11 and April 30, 2025, and will focus on reviewing grant applications related to device-based treatments for substance use disorders and the relationship between stimulants and HIV. Due to confidential information being discussed, such as personal data and potential trade secrets, these meetings will not be open to the public. Both meetings will be held virtually.

The National Institute of Allergy and Infectious Diseases will hold a closed meeting from April 14-16, 2025, to review and evaluate contract proposals related to the development of diagnostics for Mycoplasma genitalium infection. This meeting falls under specific federal regulations, which means it will not be open to the public to protect confidential and personal information. The discussions might involve trade secrets or sensitive commercial information. For more details, Dylan P. Flather, Ph.D., is the contact person available via email or phone.

The National Institutes of Health (NIH) is offering a new invention for licensing, aiming to quickly commercialize results from government-funded research. This invention involves a vaccine technology, developed by NIH, that uses adenovirus type 4 to stimulate an immune response against SARS-CoV-2. The vaccine offers benefits like durable immunity and ease of distribution and is available for companies to license. Interested parties can obtain further information and discuss collaboration opportunities by contacting Chris Kornak from the NIH.

The National Institute on Aging is holding a closed meeting on February 5, 2025, from 12:00 p.m. to 4:30 p.m. to review and evaluate grant applications regarding Alpha Herpes Viruses and Alzheimer's Disease. This meeting will be conducted virtually and will remain private to protect confidential information and personal privacy. The event has been announced as per the requirements of the Federal Advisory Committee Act, with further details available through contact person Ivan Tadeu Rebustini at the National Institute of Health.

The National Institutes of Health announced a series of upcoming closed meetings organized by the Center for Scientific Review. These meetings will review and evaluate grant applications, focusing on various topics such as Alzheimer's disease, ethical issues in research, and bioengineering. Due to the sensitive nature of the information, these meetings will not be open to the public. They will be held virtually and involve discussions on confidential trade secrets and personal information related to the grant applications.